DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal Tumors by Furst, Ariel L. & Barton, Jacqueline K.
Chemistry & Biology, Volume 22Supplemental InformationDNA Electrochemistry Shows
DNMT1 Methyltransferase Hyperactivity
in Colorectal Tumors
Ariel L. Furst, and Jacqueline K. Barton
Supplemental Data 
 
Figure S1. DNMT1 activity measured electrochemically without normalization to 
the unmethylated substrate, as shown in Figure 4. The fold excess activity measured 
electrochemically shows hyperactivity in all but two of the tissue samples.  Those that do 
not show hyperactivity have equivalent DNMT1 activity between tumor and normal 
tissue.  The data for activity on the hemimethylated substrate for the tumor tissue are 
normalized to that of the normal adjacent tissue.  
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Figure S2. DNMT1 activity measured with radioactivity without normalization to 
the unmethylated substrate, as shown in Figure 4.  The fold excess activity measured 
with radioactive labeling does not show similar hyperactivity in the tumor sample as 
when measured electrochemically.  The data for activity on the hemimethylated substrate 
for the tumor tissue are normalized to that of the normal adjacent tissue.  
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Figure S3. Sample Western blots used for quantification in Figure 5. Shown are the 
bands used for quantification of differential DNMT1 protein content in the tumor as 
compared to normal tissue.  The top bars show the DNMT1 in each tissue set as well as 
cell lysate.  The bottom bars show the loading control, Lamin A, to which each DNMT1 
concentration is normalized.  60 µg of protein per lane were loaded onto the gels.  1o 
antibody for DNMT1 (R & D) and Lamin A (Santa Cruz) is incubated overnight. Goat 
anti-rabbit 2o antibody (Abcam) or Donkey Anti Sheep for DNMT1 (Santa Cruz) is 
subsequently incubated, followed by imaging.  Quantification is performed with Li-COR 
Odyssey Image Studio software. 
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Methods and Materials 
 
DNA Synthesis and Purification 
Hexynyl-modified oligonucleotides were synthesized on an Applied Biosystems 
3400 DNA synthesizer, and unmodified complementary DNA was purchased from IDT. 
The terminal hexynyl moiety that was incorporated into the 5ʹ end of one of the strands 
was purchased from Glen Research.  DNA was deprotected and removed from solid 
support with ammonium hydroxide (60 °C for 16 h).  Following a preliminary round of 
HPLC, oligonucleotides were treated with 80% acetic acid in water for 20 minutes.  Each 
oligonucleotide was purified by high-performance liquid chromatography (HPLC) on a 
PLRP-S column (Agilent) with a gradient of acetonitrile and 50 mM ammonium acetate. 
Oligonucleotides were desalted by ethanol precipitation and quantified by ultraviolet-
visible spectrophotometry based on their extinction coefficients at 260 nm (IDT Oligo 
Analyzer).  Masses were verified by matrix-assisted laser desorption (MALDI) mass 
spectrometry.  Based on the UV-Vis quantification of the DNA, DNA duplexes were 
formed by thermally annealing equimolar amounts of single-stranded oligonucleotides in 
deoxygenated phosphate buffer (5 mM phosphate, 50 mM NaCl, pH 7.0) at 90 °C for 5 
minutes followed by slowly cooling to 25 °C. 
The following sequences were prepared: 
Alkyne: 5ʹ-C2-(CH2)6-GA CTG AGT ACT GCG CGC ACT GAT AGC-3ʹ 
Unmodified Complement: 5ʹ-GCT ATC AGT GCG CGC AGT ACT CAG TC-3ʹ 
Methylated Complement: 5ʹ-GCT ATC AGT GCG CmGC AGT ACT CAG TC-3ʹ 
The BssHII restriction site is shown in red. 
